Drug intelligence / Profile preview

12-conjugated linoleic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Conjugated linoleic acids (CLAs) are a group of positional and geometric isomers of linoleic acid found naturally in meat and dairy products from ruminant animals. The trans-10,cis-12 isomer (t10,c12-CLA), also referred to as 12-conjugated linoleic acid, is one of the two main biologically active forms present in commercial CLA supplements. This specific isomer has been studied for its anti-obesity effects—reducing body fat mass—and potential roles in modulating lipid metabolism and gene expression[5][6][8]. Mechanistically, t10,c12-CLA can decrease stearoyl-CoA desaturase activity (involved in fatty acid metabolism), reduce prostaglandin synthesis (notably PGE2), lower serum HDL cholesterol levels, and affect insulin-like growth factor-II secretion[6][8]. However, it may also increase risk factors for type 2 diabetes and heart disease by inducing hyperinsulinemia and liver steatosis[1][5]. While animal studies suggest possible benefits such as reduced inflammation or cancer risk modulation, human data remain mixed regarding efficacy for weight loss or other indications[1][4][8].

Other names
conjugated linoleic acidCLAtrans-10,cis-12 conjugated linoleic acidt10,c12-CLA
02

Targets

SCD1 (Stearoyl-CoA desaturase 1)PPAR (PPAR family)

Beyond the preview

Go deeper on 12-conjugated linoleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 12-conjugated linoleic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call